Morgan Stanley Says 'Buy The Leader In IO,' Upgrades Bristol-Myers To Overweight

By: via Benzinga
In a report published Tuesday, analysts at Morgan Stanley upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Equal-Weight to Overweight. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.